North China Pharmaceutical Co Ltd (600812) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.026x

Based on the latest financial reports, North China Pharmaceutical Co Ltd (600812) has a cash flow conversion efficiency ratio of 0.026x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥170.24 Million ≈ $24.91 Million USD) by net assets (CN¥6.67 Billion ≈ $976.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 600812 equity to assets ratio to measure how much of total assets are equity-financed.

North China Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (1998–2025)

This chart illustrates how North China Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check North China Pharmaceutical Co Ltd (600812) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

North China Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of North China Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Shanghai QiFan Cable Co Ltd SHG:605222	-0.047x
Direcional Engenharia S.A. SA:DIRR3	0.055x
Borr Drilling Ltd NYSE:BORR	0.028x
FuelCell Energy Inc NASDAQ:FCEL	-0.037x
Deluxe Corporation NYSE:DLX	0.076x
Wuxi Xinhongye Wire & Cable Co. Ltd. A SHE:301310	N/A
Hitevision Co Ltd SHE:002955	0.131x
ARB Corporation Ltd AU:ARB	0.087x

Annual Cash Flow Conversion Efficiency for North China Pharmaceutical Co Ltd (1998–2025)

The table below shows the annual cash flow conversion efficiency of North China Pharmaceutical Co Ltd from 1998 to 2025. For the full company profile with market capitalisation and key ratios, see 600812 market cap.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥6.88 Billion ≈ $1.01 Billion	CN¥1.18 Billion ≈ $172.16 Million	0.171x	-7.24%
2024-12-31	CN¥6.67 Billion ≈ $976.71 Million	CN¥1.23 Billion ≈ $179.92 Million	0.184x	+12.77%
2023-12-31	CN¥6.27 Billion ≈ $917.56 Million	CN¥1.02 Billion ≈ $149.88 Million	0.163x	+1.30%
2022-12-31	CN¥6.23 Billion ≈ $911.41 Million	CN¥1.00 Billion ≈ $146.97 Million	0.161x	+7.75%
2021-12-31	CN¥7.02 Billion ≈ $1.03 Billion	CN¥1.05 Billion ≈ $153.68 Million	0.150x	+40.40%
2020-12-31	CN¥7.06 Billion ≈ $1.03 Billion	CN¥752.15 Million ≈ $110.06 Million	0.107x	-18.20%
2019-12-31	CN¥5.62 Billion ≈ $822.98 Million	CN¥732.97 Million ≈ $107.26 Million	0.130x	-7.23%
2018-12-31	CN¥5.51 Billion ≈ $806.58 Million	CN¥774.33 Million ≈ $113.31 Million	0.140x	+158.25%
2017-12-31	CN¥5.28 Billion ≈ $772.71 Million	CN¥287.25 Million ≈ $42.03 Million	0.054x	+164.46%
2016-12-31	CN¥5.29 Billion ≈ $774.28 Million	CN¥-446.53 Million ≈ $-65.34 Million	-0.084x	-463.04%
2015-12-31	CN¥5.27 Billion ≈ $771.13 Million	CN¥122.50 Million ≈ $17.92 Million	0.023x	+34.66%
2014-12-31	CN¥5.25 Billion ≈ $767.70 Million	CN¥90.56 Million ≈ $13.25 Million	0.017x	+153.00%
2013-12-31	CN¥4.15 Billion ≈ $606.67 Million	CN¥-135.03 Million ≈ $-19.76 Million	-0.033x	-112.90%
2012-12-31	CN¥4.18 Billion ≈ $611.39 Million	CN¥-63.92 Million ≈ $-9.35 Million	-0.015x	-108.83%
2011-12-31	CN¥1.31 Billion ≈ $192.27 Million	CN¥227.60 Million ≈ $33.30 Million	0.173x	+134.21%
2010-12-31	CN¥1.18 Billion ≈ $172.92 Million	CN¥-598.35 Million ≈ $-87.56 Million	-0.506x	-144.62%
2009-12-31	CN¥890.92 Million ≈ $130.37 Million	CN¥1.01 Billion ≈ $147.96 Million	1.135x	+74.64%
2008-12-31	CN¥1.67 Billion ≈ $244.43 Million	CN¥1.09 Billion ≈ $158.85 Million	0.650x	+42.40%
2007-12-31	CN¥1.46 Billion ≈ $213.02 Million	CN¥664.37 Million ≈ $97.22 Million	0.456x	+6.25%
2006-12-31	CN¥1.39 Billion ≈ $203.42 Million	CN¥597.12 Million ≈ $87.38 Million	0.430x	+179.39%
2005-12-31	CN¥1.46 Billion ≈ $213.37 Million	CN¥224.17 Million ≈ $32.80 Million	0.154x	-14.81%
2004-12-31	CN¥1.72 Billion ≈ $251.66 Million	CN¥310.39 Million ≈ $45.42 Million	0.180x	-14.31%
2003-12-31	CN¥2.76 Billion ≈ $403.19 Million	CN¥580.32 Million ≈ $84.92 Million	0.211x	-23.91%
2002-12-31	CN¥2.67 Billion ≈ $390.38 Million	CN¥738.50 Million ≈ $108.07 Million	0.277x	+103.57%
2001-12-31	CN¥2.70 Billion ≈ $395.23 Million	CN¥367.28 Million ≈ $53.74 Million	0.136x	+175.41%
2000-12-31	CN¥2.70 Billion ≈ $395.61 Million	CN¥133.49 Million ≈ $19.53 Million	0.049x	+135.17%
1999-12-31	CN¥2.66 Billion ≈ $389.44 Million	CN¥-373.62 Million ≈ $-54.67 Million	-0.140x	+17.86%
1998-12-31	CN¥1.91 Billion ≈ $279.75 Million	CN¥-326.74 Million ≈ $-47.81 Million	-0.171x	--

About North China Pharmaceutical Co Ltd

SHG:600812 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.20 Billion

CN¥8.17 Billion CNY

Market Cap Rank

#8140 Global

#1880 in China

Share Price

CN¥4.76

Change (1 day)

+0.00%

52-Week Range

CN¥4.20 - CN¥6.90

All Time High

CN¥18.60